Crossmark

Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis

Crossref DOI link: https://doi.org/10.1016/j.clinsp.2022.100152

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Yi, Min http://orcid.org/0000-0001-7766-4882
He, Ting http://orcid.org/0000-0001-6681-5083
Wang, Kaijin http://orcid.org/0000-0001-5933-9840
Wei, Yonggang http://orcid.org/0000-0002-7062-6135
License Information

Text and Data Mining valid from 2023-01-01

Text and Data Mining valid from 2023-01-01

Version of Record valid from 2022-12-13
More Information

This article is maintained by: Elsevier

Article Title: Comparison of gefitinib plus chemotherapy versus gefitinib alone for advanced non‑small‑cell lung cancer: A meta analysis

Journal Title: Clinics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.clinsp.2022.100152

Content Type: article

Copyright: © 2022 HCFMUSP. Published by Elsevier España, S.L.U.